Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-26T03:23:48.506Z Has data issue: false hasContentIssue false
  • English
  • Français

Insights from a National Conference: “Conflicts of Interest in the Practice of Medicine”

Published online by Cambridge University Press:  01 January 2021

Aaron S. Kesselheim  and
David Orentlicher
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Introduction
Information
Journal of Law, Medicine & Ethics , Volume 40 , Issue 3 , Fall 2012 , pp. 436 - 440
Copyright
Copyright © American Society of Law, Medicine and Ethics 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kesselheim, A. S., “Should FDA Drug and Medical Device Regulation Bar State Liability Claims?” Hearing before the House of Representatives Committee on Oversight and Government Reform (Rep. Waxman, Chairman), May 14, 2008, United States Congressional Record, H. HRG 110.Google Scholar
Kesselheim, A. S. Maisel, W. H., “Conflict of Interest in Health Care Delivery: Protecting Patients' Interests,” American Journal of Therapeutics 17, no. 4 (2010): 440–443.CrossRefGoogle Scholar
Horrobin, D. F., “Non-financial Conflicts of Interest Are More Serious Than Financial Conflicts,” BMJ 318, no. 7181 (1999): 466.Google Scholar
Kissick, W. L., Medicine's Dilemmas: Infinite Needs Versus Finite Resources (New Haven, CT: Yale University Press, 1994).Google Scholar
Falit, B. P. Gross, C. P. Roberts, K. B., “Integrated Prostate Cancer Centers and Over-Utilization of IMRT: A Close Look at Fee-for-Service Medicine in Radiation Oncology,” International Journal of Radiation Oncology*Biology*Physics 76, no. 5 (2010): 1285–1288.CrossRefGoogle Scholar
Jacobson, M. Earle, C. C. Price, M. Newhouse, J. P., “How Medicare's Payment Cuts for Cancer Chemotherapy Drugs Changed Patterns of Treatment,” Health Affairs 29, no. 7 (2010): 1391–1399. Meier, B. Thomas, K., “Some Doctors Cash In by Being Their Own Pharmacist,” New York Times, July 11, 2012, at A1.CrossRefGoogle Scholar
Kowalczyk, L. Allen, S., “AG Finds Clout of Hospitals Drives Cost,” Boston Globe, January 29, 2010, at A1. Emanuel, E. J. Pearson, S. D., “It Costs More, But Is It Worth More?” New York Times, January 3, 2012.Google Scholar
Lexchin, J. Bero, L. A. Djulbegovic, B. Clark, O., “Pharmaceutical Industry Sponsorship and Research Outcome and Quality: Systematic Review,” BMJ 326, no. 7400 (2003): 1167–1170. Ridker, P. M. Torres, J., “Reported Outcomes in Major Cardiovascular Clinical Trials Funded by For-Profit and Not-For-Profit Organizations: 2000–2005,” JAMA 295, no. 19 (2006): 2270–2274.CrossRefGoogle Scholar
Kesselheim, A. S., “Of-Label Drug Use and Promotion: Balancing Public Health Goals and Commercial Speech,” American Journal of Law and Medicine 37, nos. 2 & 3 (2011): 225–257.CrossRefGoogle Scholar
Thompson, D. F., “Understanding Financial Conflicts of Interest,” New England Journal of Medicine 329, no. 8 (1993): 573–576.CrossRefGoogle Scholar
Lessig, L., Republic, Lost: How Money Corrupts Congress – And a Plan to Stop It (New York, NY: Twelve, 2011).Google Scholar
Relman, A. S., “Medical Professionalism in a Commercialized Health Care Market,” JAMA 298, no. 22 (2007): 2668–2670.CrossRefGoogle Scholar
Stossel, T. P. Stell, L. K., “Time to ‘Walk the Walk’ about Industry Ties to Enhance Health,” Nature Medicine 17, no. 4 (2011): 437–438.CrossRefGoogle Scholar
Lo, B., “The Future of Conflicts of Interest: A Call for Professional Standards,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 441–451.CrossRefGoogle Scholar
Sage, W. M., “Some Principles Require Principals: Why Banning “Conflicts of Interest” Won't Solve Incentive Problems in Biomedical Research,” Texas Law Review 85, no. 6 (2007): 1413–1463.Google Scholar
Robertson, C. Rose, S. Kesselheim, A. S., “Effect of Financial Relationships on the Behaviors of Health Care Professionals: A Review of the Evidence,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 452–466.CrossRefGoogle Scholar
Saver, R. S., “Is It Really All about the Money? Reconsidering Non-Financial Interests in Medical Research,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 467–481.CrossRefGoogle Scholar
Kesselheim, A. S. Lee, J. L. Avorn, J. Servi, A. Shrank, W. H. Choudhry, N. K., “Conflict of Interest in Oncology Publications,” Cancer 118, no. 1 (2012): 188–195.CrossRefGoogle Scholar
Chimonas, S. Patterson, L. Raveis, V. H. Rothman, D. J., “Managing Conflicts of Interest in Clinical Care: A National Survey of Policies at U.S. medical Schools,” Academic Medicine 86, no. 3 (2011): 293–299.CrossRefGoogle Scholar
Steinbrook, R. Ross, J. S., “‘Transparency Reports’” on Industry Payments to Physicians and Teaching Hospitals,” JAMA 307, no. 10 (2012): 1029–1030.CrossRefGoogle Scholar
Sah, S., “Conflicts of Interest and Your Physician: Psychological Processes That Cause Unexpected Changes in Behavior,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 482–487.CrossRefGoogle Scholar
Steinbrook, R. Lo, B., “Medical Journals and Conflicts of Interest,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 488–499.CrossRefGoogle Scholar
Greenwood, K. Coleman, C. Boozang, K., “Toward Evidence-Based Conflicts of Interest Training for Physician-Investigators,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 500–510.CrossRefGoogle Scholar
See Lo, supra note 14.Google Scholar
Rodwin, M., “Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform,” Journal of Law, Medicine & Ethics 40, no. 3 (2012): 511–522.CrossRefGoogle Scholar